Tag: pharmaceuticals
-

Covid-19 Vaccines, Therapies – 31 August 2020
The European Commission announced today a contribution of €400 million ($US 477 million) to the COVID-19 Vaccine Global Access, or Covax, consortium.
-

DoD Funding Variable Covid-19 Vaccine Technology
The U.S. Department of Defense is funding work on a Covid-19 vaccine platform that can adjust its formula to protect against future mutations in the virus.
-

Vaccine Blocks Covid-19 Infections in Animal Tests
An experimental vaccine shows in challenge tests with monkeys it protects against Covid-19 infections in nose, throat, and airways.
-

Biotechs, Univ. Labs Partner on Covid-19 Combo Therapy
Two biotechnology companies are developing a Covid-19 treatment that combines engineered antibodies and natural killer immune system cells.
-

Sanofi Acquires Immune Disease Biotech in $3.7B Deal
A developer of small-molecule therapies for autoimmune diseases, including multiple sclerosis, and other immune disorders is being acquired by Sanofi.
-

Covid-19 Vaccines, Therapies – 17 August 2020
The number of new Covid-19 therapies increased by eight over the past week to 364, while the number of therapies in clinical trials also jumped by eight.
-

Infographic – Split U.S. Decision on Covid-19 Vaccine
While the U.S. pours billions of dollars into vaccines against Covid-19 infections, a large percentage of the American public is still not ready to be vaccinated.
-

Small Biz Grant Advances Neuro Protection Drugs
An NIH award to a biotechnology company funds discovery of drugs that protect brain cells from degenerative disorders like Alzheimer’s disease.
-

A.I. Discovery Company Raises $123M in Venture Funds
A company using image analysis and deep learning to discover therapies for diseases often considered difficult to treat is raising $123 million in new venture funds.
-

Trial Testing Rare Disease Drug for Covid-19 Pneumonia
A clinical trial is underway assessing a drug approved for a rare inherited disease as a treatment for people hospitalized with pneumonia from Covid-19 infections.